共 50 条
- [31] Manufacturability and Product Quality of Novel AAV Capsids Optimized for Specific Targeting Using Capsid Library Selection in Non-Human PrimatesMOLECULAR THERAPY, 2022, 30 (04) : 534 - 534Acharya, HariChu, DavidCockrell, AdamGranados, JesseLiu, CarolMitchell, AlexMorales, HeidyPedeferri, CarrieRodden, JennaSandberg, TroySimington, ClaireSpringfield, EmilyWheeler, BrandonWheeler, JordynGoeden, NickAdamson, Laura
- [32] Recent Advances in the Analysis Full/Empty Capsid Ratio and Genome Integrity of Adeno-associated Virus (AAV) Gene Delivery VectorsCURRENT MOLECULAR MEDICINE, 2020, 20 (10) : 806 - 813Hajba, LazloGuttman, Andras
- [33] High Efficiency Downstream Processing and Enrichment of Full AAV Particles Produced from Suspension HEK293 CellsMOLECULAR THERAPY, 2020, 28 (04) : 205 - 206Maclean, AshleeMatuszek, DanielBurak, MatthewFang, KunRogers, BenjaminGee, GretchenMcNally, DavidGanesa, ShekarLoiler, Scott
- [34] Step Gradient Development for Full Particle Enrichment of AAV on Anion-Exchange Monoliths is Hindered by Inconsistent Column LotsMOLECULAR THERAPY, 2023, 31 (04) : 221 - 221Raper, Austin T.Reed, Andrew J.Hartbarger, SydneyBarber, KatyZhang, JingjingOh, Younghoon
- [35] Disease correction by intraparenchymal or cisternal delivery of a modified AAV8 capsid expressing codon optimized NAGLU for mucopolysaccharidosis type IIIB miceMOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S71 - S71Heldermon, Coy D.Hawkins, KimCoomes, AlexandraButterworth-Hosaka, ElizabethRouse, Courtney J.Kim, Mi-JungDalugdug, JustinKunta, AishwaryaRosenkrantz, ErinnKabbej, NadiaDinelli, IsabellaAi, LingbaoFalk, Darin
- [36] Disease Correction by Intraparenchymal or Cisternal Delivery of a Modified AAV8 Capsid Expressing Codon Optimized NAGLU for Mucopolysaccharidosis Type IIIB MiceMOLECULAR THERAPY, 2020, 28 (04) : 120 - 121Heldermon, Coy D.Hawkins, KimberlyButterworth-Hosaka, ElizabethRouse, Courtney J.Kim, Mi-JungDinelli, IsabellaKunta, AishwaryaRosenkrantz, ErinnKabbej, NadiaDalugdug, JustinFalk, Darin J.
- [37] Gene therapy for ALS and FTD: preclinical efficacy of AAV-hUPF1 optimized for clinical translation with improved vector genome and novel CNS capsidHUMAN GENE THERAPY, 2024, 35 (3-4) : A38 - A39Bastiaans, J.Bekier, M.Campbell, B.Gordon, P.Korobeynikov, V. A.Lettko, A.Lowry, E. R.Naeem, A.Sullivan, J. M.Unda, S.Zamatkesh, M.Barmada, S.Kaplitt, M.Shneider, N. A.Georgiadis, T.Liu, C.Nguyen-vu, T. B.Forbes, A.
- [38] Disease correction in mucopolysaccharidosis type IIIB mice by intraparenchymal or cisternal delivery of a capsid modified AAV8 codon-optimized NAGLU vectorHUMAN MOLECULAR GENETICS, 2023, 32 (03) : 417 - 430Rouse, Courtney J.Hawkins, KimberleyKabbej, NadiaDalugdug, JustinKunta, AishwaryaKim, Mi-JungSomeya, ShinichiHerbst, ZacharyGelb, MichaelDinelli, IsabellaButterworth, ElizabethFalk, Darin J.Rosenkrantz, ErinnElmohd, HamzaKhaledi, HamidMowafy, SamarAshby, FrederickHeldermon, Coy D.
- [39] Nordihydroguaiaretic Acid (NDGA) Improves Function of Antigen-Specific T-Cells Stimulated by Capsid-Optimized AAV6 VectorsMOLECULAR THERAPY, 2016, 24 : S76 - S77Zhang, DanielLing, ChenAslanidi, George
- [40] Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassetteMOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 23 : 98 - 107Kumar, Sandeep R. P.Xie, JunHu, ShilangKo, JihyeHuang, QifengBrown, Harrison C.Srivastava, AlokMarkusic, David M.Doering, Christopher B.Spencer, H. TrentSrivastava, ArunGao, GuangpingHerzog, Roland W.